Hikma Pharmaceuticals (HIK) RNS Announcements

Add to Alert list
Date Time Source Announcement
04 Jul 2017 11:02 AM
RNS
Total Voting Rights
03 Jul 2017 03:03 PM
RNS
Holding(s) in Company
30 Jun 2017 04:11 PM
RNS
Holding(s) in Company
26 Jun 2017 07:00 AM
RNS
Leadership and Structural Changes to US Business
12 Jun 2017 04:31 PM
RNS
Director/PDMR Shareholding
02 Jun 2017 04:51 PM
RNS
Total Voting Rights
31 May 2017 09:38 AM
RNS
Director/PDMR Shareholding
19 May 2017 02:44 PM
RNS
Result of AGM
19 May 2017 07:00 AM
RNS
Trading Statement
15 May 2017 03:30 PM
RNS
Director/PDMR Shareholding
11 May 2017 07:50 AM
RNS
Hikma update on ANDA for generic Advair Diskus
08 May 2017 09:23 AM
RNS
Change of Registered Address
03 May 2017 05:23 PM
RNS
Total Voting Rights
03 May 2017 10:37 AM
RNS
Change of Registered Office
28 Apr 2017 02:30 PM
RNS
Director/PDMR Shareholding
28 Apr 2017 01:57 PM
RNS
Director/PDMR Shareholding
24 Apr 2017 03:35 PM
RNS
Director/PDMR Shareholding
13 Apr 2017 08:58 AM
RNS
Director/PDMR Shareholding
13 Apr 2017 08:43 AM
RNS
Director/PDMR Shareholding
13 Apr 2017 08:42 AM
RNS
Director/PDMR Shareholding
13 Apr 2017 08:41 AM
RNS
Director/PDMR Shareholding
13 Apr 2017 08:36 AM
RNS
Director/PDMR Shareholding
11 Apr 2017 04:01 PM
RNS
Director/PDMR Shareholding
07 Apr 2017 11:55 AM
RNS
Annual Financial Report
06 Apr 2017 07:00 AM
RNS
Hikma enters into settlement agreement with Jazz
03 Apr 2017 03:59 PM
RNS
Total Voting Rights
03 Apr 2017 03:56 PM
RNS
Block listing Interim Review
27 Mar 2017 11:13 AM
RNS
Holding(s) in Company
23 Mar 2017 09:30 AM
RNS
Director/PDMR Shareholding
15 Mar 2017 07:00 AM
RNS
Final Results
10 Mar 2017 07:30 AM
RNS
Hikma launches Desvenlafaxine Succinate Tablets
08 Mar 2017 04:01 PM
RNS
Notice of Results
08 Mar 2017 01:30 PM
RNS
Director/PDMR Shareholding
01 Mar 2017 02:38 PM
RNS
Total Voting Rights
13 Feb 2017 09:19 AM
RNS
Licensing agreement with Orion for Easyhaler®
06 Feb 2017 02:27 PM
RNS
Total Voting Rights
06 Feb 2017 12:47 PM
RNS
Holding(s) in Company
18 Jan 2017 09:11 AM
RNS
Hikma receives approval for Sodium Oxybate
20 Dec 2016 03:24 PM
RNS
Director/PDMR Shareholding
20 Dec 2016 11:00 AM
RNS
Holding(s) in Company
20 Dec 2016 10:47 AM
RNS
Director/PDMR Shareholding
13 Dec 2016 01:46 PM
RNS
Director/PDMR Shareholding
12 Dec 2016 04:06 PM
RNS
Director/PDMR Shareholding
07 Dec 2016 09:35 AM
RNS
Director/PDMR Shareholding
06 Dec 2016 06:04 PM
RNS
Total Voting Rights
05 Dec 2016 12:34 PM
RNS
Director/PDMR Shareholding
02 Dec 2016 05:42 PM
RNS
Director/PDMR Shareholding
28 Nov 2016 09:59 AM
RNS
Director/PDMR Shareholding
22 Nov 2016 07:00 AM
RNS
Hikma announces agreement with Vectura
16 Nov 2016 11:12 AM
RNS
Additional Listing

Hikma Pharmaceuticals is a British multinational pharmaceutical company, founded in 1978, that develops, manufactures, and markets a wide range of generic, branded, and in-licensed pharmaceutical products, with a focus on making high-quality medicines accessible.

Hikma share price launched at 281p in 2005.

 

UK 100

Latest directors dealings